跳至主要内容
临床试验/TCTR20230829001
TCTR20230829001已完成4 期

Impact of depression specific pharmaceutical care and smartphone app in medication adherence among patients with major depressive disorders: a pilot study

Faculty of Pharmacy, Chiang Mai University, Thailand0 个研究点目标入组 36 人开始时间: 2023年8月29日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
36

研究概览

简要总结

The intervention group had a mean MARs score of higher than the control group, which had a mean score more than the control group.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • Patient were included if they were outpatient and firstly received a diagnosis of the International Classification of Diseases and Related Health Problem 10th Revision (ICD 10) with disease codes F32.0 to F32.2 by psychiatrists, aged 18 years, were willing to use smartphone app and received treatment during the data collection period, that is, from November, 2020 to February 10, 2021.

排除标准

  • They were excluded if they presented a Clinical Global Impression Severity scale (CGI-S) score greater than 6, were unable to follow up during the study, were visually impaired, hearing impaired or unable to communicate, received a diagnosis with Alzheimer's disease, dementia, neurodegenerative disorder, or a chronic disease requiring other medications.

研究者

发起方
Faculty of Pharmacy, Chiang Mai University, Thailand

相似试验